Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer
Express Pharma
FOPE opposes proposed exemption of retailers, hospitals from DPCO overcharging liability
The Federation of Pharma Entrepreneurs (FOPE) has urged the National Pharmaceutical Pricing Authority (NPPA) to reconsider a reported proposal to exempt retailers, hospitals, nursing homes and other downstream sellers from [âŠ] The post FOPE opposes proposed exemption of retailers, hospitals from DPCO overcharging liability appeared first on Express Pharma.
Read Full Article
Pharma Tech
Pineapples and green tea: FDA turns to public for new approaches to botanical drugs
The FDA is looking to modernise its regulatory framework for drugs derived from plants, algae, and fungi.
Read Full Article
Pharma Tech
Ionis nets Zanvastro US approval in first for Alexander disease
Ionis claims Zanvastro will become available to US patients with rare neurodegenerative condition, Alexander disease âin the coming weeksâ.
Read Full Article
Pharma Tech
FDA rallies HRT manufacturers amid US-wide estradiol patch shortage
The uptick in demand for HRT comes shortly after the FDA removed the long-standing black box label warning from such products.
Read Full Article
Pharma Tech
Superluminal Medicines secures $60m to advance rare obesity therapy
Superluminal Medicines has completed a $60m Series B round to support its research into therapies for rare genetic forms of obesity.
Read Full Article
Sponsored content
Featured promotional
News
Latest stories
PharmaShots
Sep 4, 2026, 12:30 PM
Samsung Bioepis Reports MHLW Approval of its Ustekinumab Biosimilar
Shots: Ref: Samsung Bioepis |  Image: Samsung Bioepis |   Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Samsung Bioepis Reports MHLW Approval of its Ustekinumab Biosimilar appeared first on PharmaShots.
Express Pharma
Sep 4, 2026, 11:35 AM
FOPE opposes proposed exemption of retailers, hospitals from DPCO overcharging liability
The Federation of Pharma Entrepreneurs (FOPE) has urged the National Pharmaceutical Pricing Authority (NPPA) to reconsider a reported proposal to exempt retailers, hospitals, nursing homes and other downstream sellers from [âŠ] The post FOPE opposes proposed exemption of retailers, hospitals from DPCO overcharging liability appeared first on Express Pharma.
PharmaShots
Sep 4, 2026, 11:30 AM
Milestone Pharmaceuticals Reports the NMPA Approval of Etripamil Nasal Spray for PSVT
Shots: Ref: Globenewswire |  Image: Milestone |   Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Milestone Pharmaceuticals Reports the NMPA Approval of Etripamil Nasal Spray for PSVT appeared first on PharmaShots.
ET Pharma
Sep 4, 2026, 10:42 AM
uniQure seeks US approval for Huntington's gene therapy after FDA reversal
Huntington's disease is a rare inherited brain disorder that causes movement difficulties and triggers behavioural changes and cognitive âdecline. No approved â drugs â currently exist that help slow progression.
PharmaShots
Sep 4, 2026, 10:30 AM
Globus Medical Receives the CE Mark for Excelsius3D
Shots: Ref: Globenewswire |  Image: Globus Medical |   Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Globus Medical Receives the CE Mark for Excelsius3D appeared first on PharmaShots.
Pharma Tech
Sep 4, 2026, 10:29 AM
Pineapples and green tea: FDA turns to public for new approaches to botanical drugs
The FDA is looking to modernise its regulatory framework for drugs derived from plants, algae, and fungi.
News
Latest industry coverage
Google News
Sep 5, 2026, 2:26 AM
Asia-Pacific Aluminum Crimp-on Seals - Market Analysis, Forecast, Size, Trends and Insights - IndexBox
Asia-Pacific Aluminum Crimp-on Seals - Market Analysis, Forecast, Size, Trends and Insights  IndexBox
Google News
Sep 4, 2026, 11:55 PM
Novartis Says Closely Watched Cholesterol Study Failed to Meet Goal - WSJ
Novartis Says Closely Watched Cholesterol Study Failed to Meet Goal  WSJ
Google News
Sep 4, 2026, 11:47 PM
Retatutride: How the hunger for a new weight loss drug is feeding an industry of fakes - BBC
Retatutride: How the hunger for a new weight loss drug is feeding an industry of fakes  BBC
Google News
Sep 4, 2026, 11:30 PM
Novartis, Ionis' experimental heart drug misses key goal in closely watched trial - Reuters
Novartis, Ionis' experimental heart drug misses key goal in closely watched trial  Reuters
Google News
Sep 4, 2026, 11:10 PM
Royalty Pharma Announces Novartis HORIZON Pelacarsen Trial Results and Updates Return Outlook on Ionis Funding Agreement - Quiver Quantitative
Royalty Pharma Announces Novartis HORIZON Pelacarsen Trial Results and Updates Return Outlook on Ionis Funding Agreement  Quiver Quantitative
Google News
Sep 4, 2026, 10:35 PM
FDA Approves Ionis Pharma Drug, the First for Ultra-Rare Alexander Disease - MedCity News
FDA Approves Ionis Pharma Drug, the First for Ultra-Rare Alexander Disease  MedCity News
Google News
Sep 4, 2026, 9:45 PM
Merck (MRK) Sees a More Significant Dip Than Broader Market: Some Facts to Know - finance.yahoo.com
Merck (MRK) Sees a More Significant Dip Than Broader Market: Some Facts to Know  finance.yahoo.com
Google News
Sep 4, 2026, 9:25 PM
Novartis, Ionis Tumble On Surprise Flop For Heart Drug - Investor's Business Daily
Novartis, Ionis Tumble On Surprise Flop For Heart Drug  Investor's Business Daily
Google News
Sep 4, 2026, 9:13 PM
Novartisâ experimental cardiovascular drug fails a pivotal study - STAT
Novartisâ experimental cardiovascular drug fails a pivotal study  STAT
Sponsored placement
Featured promotions
Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer